⚠️ System Notice: The registration module is now online. Wire transfer payments in the ordering module are now active. Credit card payment implementation will continue until 20.04.2026.
Shopping Cart
CATEGORIES

Anti-AAAS Polyclonal Antibody

Product classification
Antibodies Primary Antibodies
Catalog No CAB.13682
Antibody overview
CAB.13682 Antibodies
Anti-AAAS Polyclonal Antibody
Ordering
Available Variants
2 Variants
Change View
50ul
SKU
CAB.13682-50ul
Price
€200.00
Available – Dispatch in 14 days
100ul
SKU
CAB.13682-100ul
Price
€335.00
Available – Dispatch in 14 days
Availability & Stock Pack SKU Price (EUR)
Available – Dispatch in 14 days
Global Network - International delivery
50ul CAB.13682-50ul €200.00
Available – Dispatch in 14 days
Global Network - International delivery
100ul CAB.13682-100ul €335.00
Quick page guide: Compare pack sizes, review validated applications and access product documents from this section.
Recommended Dilution
WB 1:200-1000
IHC-P 1:10-100
Validated Application Key
IHC-P
Validated application
IHC-P - Immunohistochemistry (Paraffin-embedded sections)
WB
Validated application
WB - Western Blotting
Technical Specifications
Catalog No CAB.13682
Product Name Anti-AAAS Polyclonal Antibody
Isotype IgG
Calculated MW 60kDa
Immunogen Recombinant protein of human AAAS
Public Immunogen Range N/A
Host Rabbit
Clone Type Polyclonal Antibody
Reactivity Mouse;Human
Application IHC-P;WB
Subcellular Location Cytoplasm
Purification Method CABfinity purification
Storage Buffer pH7.4 PBS,0.05% NaN3,40% Glycerol.
Storage Store at -20℃. Avoid freeze / thaw cycles.

Background

The protein encoded by this gene is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome. Two transcript variants encoding different isoforms have been found for this gene.

Protocol / Instructions

Recommended workflow
Optimized handling and experimental guidance
Review the suggested sequence below before starting the assay to keep sample handling, incubation, and downstream interpretation aligned.
Lab-ready steps

The Anti-AAAS Polyclonal Antibody is a rabbit-derived antibody that recognizes the AAAS protein in human and mouse samples. This antibody has been validated for use in Western Blotting (WB) and Immunohistochemistry-Paraffin (IHC-P) applications.

## Western Blotting Protocol

For Western Blotting, the recommended dilution is 1:200-1000. The following reagents and buffers are required: sample buffer, running buffer, transfer buffer, and blocking buffer. Sample preparation involves lysing cells or tissues in sample buffer, followed by separation on an SDS-PAGE gel and transfer to a membrane. The membrane is then blocked with blocking buffer and incubated with the Anti-AAAS Polyclonal Antibody. CABter washing, the membrane is incubated with a secondary antibody conjugated to a detection system. Technical notes: the optimal dilution and incubation time may vary depending on the specific sample and experimental conditions.

## IHC-P Protocol

For Immunohistochemistry-Paraffin, the recommended dilution is 1:10-100. The following reagents and buffers are required: xylene, ethanol, antigen retrieval buffer, and blocking buffer. Sample preparation involves deparaffinizing and rehydrating tissue sections, followed by antigen retrieval and blocking with blocking buffer. The sections are then incubated with the Anti-AAAS Polyclonal Antibody, followed by washing and incubation with a secondary antibody conjugated to a detection system. Technical notes: the optimal dilution and incubation time may vary depending on the specific tissue and experimental conditions.

Precautions

Store at -20°C, handle with care, use appropriate controls, and optimize antibody dilution and incubation time for best results.

Validation Images

Anti-AAAS Polyclonal Antibody Figure 1
Fig.1. Validation data.
Anti-AAAS Polyclonal Antibody Figure 2
Fig.2. Validation data.